ANAVEX LIFE SCIENCES CORP. (NASDAQ:AVXL) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
On December 28, 2020 Anavex Life Sciences Corp. (the “Company”) issued a press release reporting financial results for its fiscal year ended September 30, 2020. A copy of the press release is furnished as Exhibit 99.1 to this Current Report.
The information furnished to Item 2.02 of this Current Report, including Exhibit 99.1 hereto, shall not be considered “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly sets forth in such future filing that such information is to be considered “filed” or incorporated by reference therein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| 99.1 | Press Release of the Company dated December 28, 2020 |
ANAVEX LIFE SCIENCES CORP. Exhibit
EX-99.1 2 e2308_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – December 28,…
To view the full exhibit click here
